NASDAQ:INCY

Incyte Stock Insider Trading

Healthcare > Biotechnology

Buy INCY

*Your capital is at risk

$114.23

-2.48 (-2.12%)

At Close: Jul 13, 2026

Incyte Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -43.57. In total, the insiders bought 727.26K and sold 256.21K INCY shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	-43.57
● Buy	727.26K shares
● Sell	256.21K shares
69% Buy Activity Moderate Negative Correlation
Buy Signal Low Confidence May 04, 2026 Analysis Breakdown: Signal is highly questionable due to a strongly contradictory negative Insider Power Score of -43.57. Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date	Type	Person	Role	Amount
Jul 02, 2026 Sell	Common Stock F-InKind	Tray Thomas Principal Accounting Officer	Officer	477 Value: $55.7K
Jul 02, 2026 Sell	Common Stock F-InKind	Stein Steven H Cmo & Head Of Late-stage Dev.	Officer	2 177 Value: $254.4K
Jul 02, 2026 Sell	Common Stock F-InKind	Meury William Chief Executive Officer	CEO / President	4 779 Value: $558.5K
Jul 02, 2026 Sell	Common Stock F-InKind	Mayes Patrick A EVP & Chief Scientific Officer	Officer	350 Value: $40.9K
Jun 30, 2026 Buy	Common Stock A-Award	Baker Bros. Advisors Lp	Director	400 Value: $45.3K
Jun 30, 2026 Buy	Common Stock A-Award	Baker Bros. Advisors Lp	Director	400 Value: $45.3K
Jun 30, 2026 Buy	Common Stock A-Award	Harrigan Edmund Director	Director	255 Value: $28.9K
Jun 30, 2026 Buy	Common Stock A-Award	Clancy Paul J Director	Director	252 Value: $28.6K
Jun 08, 2026 Buy	Non Qualfied Stock Option (right to buy) A-Award	Brawley Otis W Director	Director	6 111 Value: $615.0K
Jun 08, 2026 Buy	Non Qualfied Stock Option (right to buy) A-Award	Clancy Paul J Director	Director	6 111 Value: $615.0K
Jun 08, 2026 Buy	Non Qualfied Stock Option (right to buy) A-Award	Fouse Jacqualyn A Director	Director	6 111 Value: $615.0K
Jun 08, 2026 Buy	Common Stock A-Award	Clancy Paul J Director	Director	1 642 Value: $165.3K
Jun 08, 2026 Buy	Common Stock A-Award	Baker Bros. Advisors Lp	Director	1 642 Value: $165.3K
Jun 08, 2026 Buy	Common Stock A-Award	Baker Bros. Advisors Lp	Director	1 642 Value: $165.3K
Jun 08, 2026 Buy	Non-Qualified Stock Options (right to buy) A-Award	Baker Bros. Advisors Lp	Director	6 111 Value: $615.0K
Jun 08, 2026 Buy	Non Qualfied Stock Option (right to buy) A-Award	Harrigan Edmund Director	Director	6 111 Value: $615.0K
Jun 08, 2026 Buy	Common Stock A-Award	Harrigan Edmund Director	Director	1 642 Value: $165.3K
Jun 08, 2026 Buy	Non Qualfied Stock Option (right to buy) A-Award	High Katherine A Director	Director	6 111 Value: $615.0K
Jun 08, 2026 Buy	Common Stock A-Award	High Katherine A Director	Director	1 642 Value: $165.3K
Jun 08, 2026 Buy	Non Qualfied Stock Option (right to buy) A-Award	Bienaime Jean Jacques Director	Director	6 111 Value: $615.0K
Jun 08, 2026 Buy	Common Stock A-Award	Bienaime Jean Jacques Director	Director	1 642 Value: $165.3K
Jun 08, 2026 Buy	Common Stock A-Award	Fouse Jacqualyn A Director	Director	1 642 Value: $165.3K
Jun 08, 2026 Buy	Common Stock A-Award	Brawley Otis W Director	Director	1 642 Value: $165.3K
Jun 04, 2026 Sell	Common Stock S-Sale	Tray Thomas Principal Accounting Officer	Officer	2 639 Value: $263.9K
Jun 04, 2026 Buy	Common Stock M-Exempt	Tray Thomas Principal Accounting Officer	Officer	2 639 Value: $221.2K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT INCYTE CORPORATION

Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as oncogenic drivers in various liquid and solid tumor types; and ICLUSIG, a kinase inhibitor to treat chr...

Read Full Profile Here